117 related articles for article (PubMed ID: 28923935)
41. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
42. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
Osburn DL; Shao G; Seidel HM; Schulman IG
Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
44. Loss of myeloid-specific lamin A/C drives lung metastasis through Gfi-1 and C/EBPε-mediated granulocytic differentiation.
Ishii H; Park WY; So J; Kuhn S; Koparde VN; Pang Y; Greten TF; Hollander MC; Yang L
Mol Carcinog; 2020 Jul; 59(7):679-690. PubMed ID: 31912614
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.
Zaynagetdinov R; Sherrill TP; Gleaves LA; McLoed AG; Saxon JA; Habermann AC; Connelly L; Dulek D; Peebles RS; Fingleton B; Yull FE; Stathopoulos GT; Blackwell TS
Cancer Res; 2015 Apr; 75(8):1624-1634. PubMed ID: 25691457
[TBL] [Abstract][Full Text] [Related]
46. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site.
Li B; Vincent A; Cates J; Brantley-Sieders DM; Polk DB; Young PP
Cancer Res; 2009 Jan; 69(1):338-48. PubMed ID: 19118019
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch.
Yasmin R; Kannan-Thulasiraman P; Kagechika H; Dawson MI; Noy N
J Mol Biol; 2010 Apr; 397(5):1121-31. PubMed ID: 20188110
[TBL] [Abstract][Full Text] [Related]
48. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.
Horowitz NA; Blevins EA; Miller WM; Perry AR; Talmage KE; Mullins ES; Flick MJ; Queiroz KC; Shi K; Spek CA; Conway EM; Monia BP; Weiler H; Degen JL; Palumbo JS
Blood; 2011 Sep; 118(10):2889-95. PubMed ID: 21788337
[TBL] [Abstract][Full Text] [Related]
49. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
[TBL] [Abstract][Full Text] [Related]
50. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.
Malik G; Knowles LM; Dhir R; Xu S; Yang S; Ruoslahti E; Pilch J
Cancer Res; 2010 Jun; 70(11):4327-34. PubMed ID: 20501851
[TBL] [Abstract][Full Text] [Related]
51. Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression.
Núñez V; Alameda D; Rico D; Mota R; Gonzalo P; Cedenilla M; Fischer T; Boscá L; Glass CK; Arroyo AG; Ricote M
Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10626-31. PubMed ID: 20498053
[TBL] [Abstract][Full Text] [Related]
52. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.
Kaczanowska S; Beury DW; Gopalan V; Tycko AK; Qin H; Clements ME; Drake J; Nwanze C; Murgai M; Rae Z; Ju W; Alexander KA; Kline J; Contreras CF; Wessel KM; Patel S; Hannenhalli S; Kelly MC; Kaplan RN
Cell; 2021 Apr; 184(8):2033-2052.e21. PubMed ID: 33765443
[TBL] [Abstract][Full Text] [Related]
53. Endogenous DEL-1 restrains melanoma lung metastasis by limiting myeloid cell-associated lung inflammation.
Hyun YM; Seo SU; Choi WS; Kwon HJ; Kim DY; Jeong S; Kang GY; Yi E; Kim M; Ryu HJ; Looney MR; Choi EY; Kim HS
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33158867
[TBL] [Abstract][Full Text] [Related]
54. Inflammation joins the "niche".
Peinado H; Rafii S; Lyden D
Cancer Cell; 2008 Nov; 14(5):347-9. PubMed ID: 18977322
[TBL] [Abstract][Full Text] [Related]
55. A Long-Distance Relay-tionship between Tumor and Bone.
Soukup K; Joyce JA
Immunity; 2018 Jan; 48(1):13-16. PubMed ID: 29343434
[TBL] [Abstract][Full Text] [Related]
56. Myeloid-cell differentiation redefined in cancer.
Wynn TA
Nat Immunol; 2013 Mar; 14(3):197-9. PubMed ID: 23416669
[TBL] [Abstract][Full Text] [Related]
57. Retinoid X Receptor Activation Alters the Chromatin Landscape To Commit Mesenchymal Stem Cells to the Adipose Lineage.
Shoucri BM; Martinez ES; Abreo TJ; Hung VT; Moosova Z; Shioda T; Blumberg B
Endocrinology; 2017 Oct; 158(10):3109-3125. PubMed ID: 28977589
[TBL] [Abstract][Full Text] [Related]
58. De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis.
Sandor LF; Huh JB; Benko P; Hiraga T; Poliska S; Dobo-Nagy C; Simpson JP; Homer NZM; Mahata B; Gyori DS
Cell Rep; 2024 Mar; 43(3):113936. PubMed ID: 38489269
[TBL] [Abstract][Full Text] [Related]
59. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
Leal AS; Hung PY; Chowdhury AS; Liby KT
Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
[TBL] [Abstract][Full Text] [Related]
60. Epigenomic regulation of macrophage polarization: Where do the nuclear receptors belong?
Czimmerer Z; Nagy L
Immunol Rev; 2023 Aug; 317(1):152-165. PubMed ID: 37074820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
